For over 30 years, Guthrie has been conducting clinical trials in the gastroenterology (GI) department.
Local access to leading-edge research
As a Guthrie patient you may have an opportunity to take part in clinical research trials for celiac disease, Crohn’s disease, ulcerative colitis, reflux disease, hepatitis and many more gastroenterology disease states.
Clinical trials study new ways to prevent, detect and treat GI disease. If you take part in research, you help advance new investigational medical therapies. Research subjects receive excellent care locally from the Guthrie GI team, while still being able to access cutting-edge therapies offered in large university settings and metropolitan areas.
GI trials involve preventive measures and investigational treatments and medicines. Your physician can present you with options and help you decide if a clinical trial is right for you.
Most clinical trials offered at Guthrie are phase 2 or phase 3 studies which measure safety and efficacy (whether the investigational treatment benefits a specific group of patients).
We work with multiple labs, pharmaceutical groups, and biotech companies to offer you the chance to get innovative treatments and novel therapies, and to assist with the future of gastroenterology care.